S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|ALK-Abello Cuts Fiscal Year Guidance On Deferred Milestone Payment (2013/11/8)|
|ALK's partner in North America, Merck, reports Phase III data on investigational grass sublingual allergy immunotherapy tablet (2013/11/9)|
|Ventana receives approval from China's FDA for first fully automated IHC companion diagnostic identifying ALK protein expression in lung cancer patients (2013/9/11)|
|CORRECTING and REPLACING Deutsche Bank Appointed as Depositary Bank for the Sponsored Level I American Depositary Receipt Program of ALK-Abelló A/S (2013/9/6)|
|Alkermes Receives Fast Track Designation for ALKS 5461 for Major Depressive Disorder (2013/10/10)|
|Alkermes Announces Alignment with FDA on Plans for Pivotal Program for ALKS 5461 for Major Depressive Disorder (2013/10/9)|
|TESARO Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013 (2013/9/29)|
|TRADE NEWS: Agilent Technologies Expands Catalog of SureFISH Break-Apart Probes (2013/11/13)|
|Pfizer’s XALKORI® Granted Regular FDA Approval (2013/11/21)|
|Alkermes’ Corporate Presentation to be Webcast at the Morgan Stanley Global Healthcare Conference ()|
Click above to view more mutual fund data and stats for alk - Alkane Resources Ltd..